BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32000356)

  • 1. A long-term retrospective study on sporadic Burkitt lymphoma in chinese population.
    Yang X; Huang Q; Li A; Chen Y; Xu W; Li J; Wang Y; Fang Y
    Medicine (Baltimore); 2020 Jan; 99(5):e18438. PubMed ID: 32000356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study.
    Chen MT; Pan F; Chen YC; Zhang W; Lv HJ; Wang Z; Hong HM; Fang XJ; Wang YW; Pan T; Zou LQ; Guo HQ; Xie K; Chen LM; Li XQ; Yao YY; Chen ZG; Weng HW; Li XD; Shen YY; Zhou H; Xue HW; Zhang HL; Huang H; Lin TY
    BMC Cancer; 2022 Jan; 22(1):45. PubMed ID: 34996395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.
    Park YH; Kim WS; Kang HJ; Na II; Ryoo BY; Yang SH; Lee SS; Uhm JE; Kim K; Jung CW; Park K; Ko YH
    Ann Hematol; 2006 May; 85(5):285-90. PubMed ID: 16518604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of prognostic factors in children and adolescents with Burkitt and Diffuse Large B-Cell Lymphoma treated with the AIEOP LNH-97 protocol.
    Pillon M; Mussolin L; Carraro E; Conter V; Aricò M; Vinti L; Garaventa A; Piglione M; Buffardi S; Sala A; Santoro N; Lo Nigro L; Mura R; Tondo A; Casale F; Farruggia P; Pierani P; Cesaro S; d'Amore ES; Basso G
    Br J Haematol; 2016 Nov; 175(3):467-475. PubMed ID: 27392319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 88 BL Patients in Japan.
    Satou A; Asano N; Kato S; Elsayed AA; Nakamura N; Miyoshi H; Ohshima K; Nakamura S
    Am J Surg Pathol; 2017 Mar; 41(3):389-395. PubMed ID: 28079574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rhinologic manifestations of Burkitt Lymphoma in a pediatric population: Case series and systematic review.
    Hong X; Khalife S; Bouhabel S; Bernard C; Daniel SJ; Manoukian JJ; Nguyen LHP
    Int J Pediatr Otorhinolaryngol; 2019 Jun; 121():127-136. PubMed ID: 30897372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database.
    Castillo JJ; Winer ES; Olszewski AJ
    Cancer; 2013 Oct; 119(20):3672-9. PubMed ID: 23913575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term survival of children with Burkitt lymphoma in Malawi after cyclophosphamide monotherapy.
    Kazembe P; Hesseling PB; Griffin BE; Lampert I; Wessels G
    Med Pediatr Oncol; 2003 Jan; 40(1):23-5. PubMed ID: 12426682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of JL1 in Burkitt lymphoma is associated with improved overall survival.
    Hwang I; Go H; Jeon YK; Ko YH; Yoon DH; Suh C; Huh JR; Lee H; Gil M; Park CS
    Virchows Arch; 2011 Oct; 459(4):353-9. PubMed ID: 21814778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.
    Mukhtar F; Boffetta P; Risch HA; Park JY; Bubu OM; Womack L; Tran TV; Zgibor JC; Luu HN
    Int J Cancer; 2017 Apr; 140(7):1494-1502. PubMed ID: 28006853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of aggressive B-cell lymphomas including B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell and Burkitt lymphomas: a study of 44 patients from Argentina.
    Bürgesser MV; Gualco G; Diller A; Natkunam Y; Bacchi CE
    Ann Diagn Pathol; 2013 Jun; 17(3):250-5. PubMed ID: 23246412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL.
    Smyth L; Browne PV; Conneally E; Flynn C; Hayden P; Jeffers M; O'Brien D; Quinn F; Kelly J; Perera M; Crotty GM; Leahy M; Hennessy B; Jackson F; Ryan M; Vandenberghe E
    Ir J Med Sci; 2016 Nov; 185(4):773-777. PubMed ID: 25843016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary chromosomal abnormalities predict outcome in pediatric and adult high-stage Burkitt lymphoma.
    Onciu M; Schlette E; Zhou Y; Raimondi SC; Giles FJ; Kantarjian HM; Medeiros LJ; Ribeiro RC; Pui CH; Sandlund JT
    Cancer; 2006 Sep; 107(5):1084-92. PubMed ID: 16862570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkitt lymphoma (BL): reclassification of 39 lymphomas diagnosed as BL or Burkitt-like lymphoma in the past based on immunohistochemistry and fluorescence in situ hybridization.
    Kodet R; Mrhalová M; Stejskalová E; Kabícková E
    Cesk Patol; 2011 Jul; 47(3):106-14. PubMed ID: 21887927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic role of ΔMTV and ΔTLG in Burkitt lymphoma.
    Albano D; Re A; Tucci A; Giubbini R; Bertagna F
    Ann Nucl Med; 2019 Apr; 33(4):280-287. PubMed ID: 30788775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Italian cancer figures, report 2012: Cancer in children and adolescents.
    ; ;
    Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in survival of patients with Burkitt lymphoma/leukemia in the USA: an analysis of 3691 cases.
    Costa LJ; Xavier AC; Wahlquist AE; Hill EG
    Blood; 2013 Jun; 121(24):4861-6. PubMed ID: 23641015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low incidence of MYC/BCL2 double-hit in Burkitt lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Kiyasu J; Kimura Y; Niino D; Ohshima K
    Pathol Int; 2015 Sep; 65(9):486-9. PubMed ID: 26182827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.